GlassScriptPhysician profile
Joseph Kim
NPI 1295804052
$46,742.15
in general payments reported to CMS, 2019-2025
18 companies · $4,345 in 2025
The $4,345 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $18K · 2021: $117 · 2022: $492 · 2023: $1,509 · 2024: $3,633 · 2025: $4,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,780 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Travel and Lodging: $2,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,779.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Travel and Lodging | $2,457.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14,327.87 | 2019-2024 | Tecentriq |
| Sirtex Medical INC | $12,907.80 | 2019-2025 | Sir-Spheres Microspheres |
| Merck Sharp & Dohme LLC | $10,000.00 | 2020 | |
| Intuitive Surgical, INC. | $4,327.19 | 2019-2020 | |
| Elucent Medical | $1,224.16 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $689.58 | 2019-2023 | Onivyde |
| Tempus Ai, INC | $582.92 | 2024-2025 | Xt Cdx, Tempus Pixel |
| Medtronic, INC. | $570.04 | 2024-2025 | Signia, Ligasure |
| Angiodynamics, INC. | $540.99 | 2022-2025 | Nanoknife |
| Intera Oncology, INC | $296.86 | 2022-2025 | Intera |
| Exelixis INC. | $271.26 | 2023 | Cabometyx |
| Bk Medical Holding Company INC. | $189.58 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Davol INC. | $184.38 | 2023 | Phasix Mesh |
| Ge Healthcare | $146.68 | 2025 | |
| Genentech, INC. | $136.80 | 2023 | Tecentriq, Avastin |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $130.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $129.88 | 2025 | |
| Epizyme, INC. | $85.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.